S2E8: Pharma in Flux: Navigating Regulatory Uncertainty and Manufacturing Momentum in 2025
The Life Science Effect
In this mid-2025 update, The Life Science Effect explores the latest trends in pharma and medical devices—from regulatory upheaval under RFK Jr. and Dr. Makary to continued momentum in U.S. drug manufacturing. Learn how industry leaders are navigating clinical trial delays, FDA uncertainty, and global GLP-1 market expansion. Full transcript: Hey, everybody. Steve again, welcome back to the Life Science effect. If you're listening in the future, which most of you probably are, this may once again sound prophetic or maybe like a time capsule from a moment of flux. Today's updates a...
info_outline
S2E7: Prophetic Musings. Navigating Uncertainty in Life Sciences
The Life Science Effect
Production Note: Since this episode was recorded, Robert F. Kennedy, Jr. was confirmed as the head of HHS. Steve didn't know that at the time but it was a pretty good bet, so the analysis holds up. In this topical episode of The Life Science Effect, Steve explores the uncertainties facing the life sciences industry under the new U.S. administration. He discusses the potential impact of leadership changes at HHS and the FDA, industry perspectives from Eli Lilly CEO Dave Ricks, and the significance of multi-billion dollar pharmaceutical manufacturing investments in the U.S. Through...
info_outline
S2E6: BPM's Commitment to DEIB is Unwavering
The Life Science Effect
In this timely and thought-provoking episode, Steve Vinson discusses the current landscape of diversity, equity, and inclusion (DEI) in the corporate world amid increasing political and business pushback. He reflects on recent headlines about major corporations rolling back DEI initiatives and contrasts that with companies like Costco and JP Morgan Chase, which are standing firm in their commitment to inclusiveness. Steve also shares BPM Associates’ perspective, reaffirming that DEI is more than just an initiative - it is a core value embedded in the company’s culture. He highlights how...
info_outline
S2E5: Denise Bachman, COO of BPM Associates
The Life Science Effect
In this episode of the Life Science Effect, host Steve Vinson interviews Denise Bachman, Chief Operating Officer of BPM Associates. Denise shares insights into BPM Associates, a life sciences consultancy known for its unique approach and core values. She discusses her journey as a project manager and the importance of building a supportive company culture. Denise emphasizes the significance of high-trust relationships and effective teamwork in achieving project success. She also recounts a challenging project experience, highlighting the impact of leadership and resistance to change on project...
info_outline
S2E4: Jeremy Opperman, Founder and Beating Heart of BPM Associates
The Life Science Effect
Steve Vinson interviews Jeremy Opperman, the founder of BPM Associates. Jeremy shares his journey from growing up in a small business environment to starting his own company, BPM Associates, which specializes in life science project delivery. He emphasizes the importance of quality and people-focused relationships in his business. Jeremy also discusses the challenges and successes of building BPM Associates over the past 10 years, with the support of his wife Amanda. The episode highlights Jeremy's intentional approach to business, his commitment to high-quality service, and the importance of...
info_outline
S2E3: What Do We Do?
The Life Science Effect
In Season 2, Episode 3 of *The Life Science Effect*, Steve Vinson discusses BPM Associates' work. He explains BPM’s core purpose and values—supporting people, fostering teamwork, and reducing turnover in the life sciences industry. Through personal stories, Steve illustrates the challenge of defining “what we do” in simple terms and describes BPM’s approach to managing projects in pharmaceuticals, including combination product scaling, regulatory compliance, and facility expansions. Emphasizing people-centered project management, BPM seeks to avoid burnout while meeting timelines and...
info_outline
S2E2: How Do We Do It?
The Life Science Effect
Host Steve Vinson continues exploring BPM Associates' core philosophy, following up on Simon Sinek’s idea of starting with "why." In Episode 1, Steve shared why BPM does what it does—now, he turns to "how" they do it. Before diving into the business side, Steve shares a humorous and mostly true story about his recovery from outpatient surgery, which highlights the value of a great work environment and how it can translate into better outcomes for patients, employees, and even clients. Steve emphasizes that BPM’s approach centers on strong leadership, effective project management, and...
info_outline
S2E1: BPM's "Why"
The Life Science Effect
In late 2021, the COO, founder, and CEO of BPM Associates gathered to do their annual planning. They decided that they needed a new vision statement that would resonate with their core ideology. They watched Simon Sinek's TED Talk on starting with "why" and realized that people don't buy from BPM or work for BPM because of what they do, but because of why they do it. They decided to focus on doing business with those who believe in their "why", even if it meant walking away from some opportunities. They wanted to create a company that attracted outstanding people and provided top talent for...
info_outline
Season 2 Trailer (re)introducing BPM Associates
The Life Science Effect
We're back! In this trailer, Steve explains why it has been so long, how we can have a Season 2 when there wasn't really a Season 1, and what you can expect from this season of the show. Music: Acid Jazz-Kevin MacLeod used under the Creative Commons Attribution 4.0 International License Acoustic Motivation-Corna Media used under the Creative Commons Attribution 4.0 International License
info_outline
035: Steve Vinson | Leaders Reinforce Culture
The Life Science Effect
I've heard it said that culture beats strategy. I believe that. I also believe culture beats tactics and process and procedure and technique. In this episode (another solo episode), I will relate a recent story in which I had the chance to stand up and reinforce the safety culture of my client. It may not be for everybody. It may not be "life science" specific. That's okay. Not to worry. Life Science talk returns next time and guests return late summer or early fall this year. Thanks for your support! Thanks to our sponsor BPM Associates -
info_outline16 Tech is the future of collaboration in downtown Indianapolis. It will bring together the talent, capital, and technology to make innovation happen.
Robert Coy is President and CEO of 16 Tech Community Corporation Inc., the entity overseeing the development of the 16 Tech innovation community. As President, Coy leads the development of 16 Tech into a major hub for scientific research, technology innovation, entrepreneurial activity and talent development, retention and attraction.
Prior to 16 Tech, Coy was President and CEO of CincyTech, a venture development organization that accelerated the growth of start-up bioscience, healthcare, technology and advanced manufacturing companies in Southwest Ohio. Under Coy’s leadership for more than 11 years, CincyTech invested in 70 startups that raised more than $680 million in seed, early and late stage capital and that today employ nearly 1,000 people.
Coy has held entrepreneurial and economic development leadership positions with public and private institutions over the past 32 years in Ohio, Missouri, Delaware and Pennsylvania.
Prior to joining CincyTech, Coy was senior vice president for entrepreneurial development and of economic development at the St. Louis Regional Chamber and Growth Association, where he co-founded the St. Louis Arch Angels, a group of individuals who invest in early-stage companies in the St. Louis region.
In Delaware, Coy served as the principal economic adviser to the governor, established a seed fund to invest in technology start-up companies and developed initiatives to promote technology partnerships between universities and businesses. In Pennsylvania, he served as executive director of the Ben Franklin Partnership Program, the state’s premier technology development program that invests in start-up companies.
Coy earned a master’s degree from University of Notre Dame and a bachelor of arts degree from Pennsylvania State University.